SG152922A1 - Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body - Google Patents

Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body

Info

Publication number
SG152922A1
SG152922A1 SG200705275-6A SG2007052756A SG152922A1 SG 152922 A1 SG152922 A1 SG 152922A1 SG 2007052756 A SG2007052756 A SG 2007052756A SG 152922 A1 SG152922 A1 SG 152922A1
Authority
SG
Singapore
Prior art keywords
metabolism
methods
sugars
drugs
fatty acids
Prior art date
Application number
SG200705275-6A
Other languages
English (en)
Inventor
Marc K Hellerstein
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of SG152922A1 publication Critical patent/SG152922A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
SG200705275-6A 2002-11-04 2003-11-04 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body SG152922A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42396402P 2002-11-04 2002-11-04

Publications (1)

Publication Number Publication Date
SG152922A1 true SG152922A1 (en) 2009-06-29

Family

ID=32312729

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200705275-6A SG152922A1 (en) 2002-11-04 2003-11-04 Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body

Country Status (7)

Country Link
US (2) US7504233B2 (fr)
EP (1) EP1558293A4 (fr)
JP (1) JP4611025B2 (fr)
AU (1) AU2003291731B2 (fr)
CA (1) CA2504313C (fr)
SG (1) SG152922A1 (fr)
WO (1) WO2004042360A2 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910403A (en) 1997-05-15 1999-06-08 The Regents Of University Of California Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
US7001587B2 (en) * 2001-10-24 2006-02-21 The Regents Of The University Of California Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water
DE60324393D1 (de) * 2002-02-12 2008-12-11 Univ California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
US20030224420A1 (en) * 2002-04-05 2003-12-04 Hellerstein Marc K. Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
WO2004011426A2 (fr) 2002-07-30 2004-02-05 The Regents Of The University Of California Procede de mesure automatique a grande echelle des taux de flux moleculaire proteomique ou organeomique par spectrometrie de masse
WO2004021863A2 (fr) * 2002-09-04 2004-03-18 The Regents Of The University Of California Procedes de mesure des vitesses de replication et du taux de mortalite d'agents microbiens infectieux dans un organisme hote infecte
ATE415486T1 (de) * 2002-09-13 2008-12-15 Univ California Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese
AU2003275037A1 (en) * 2002-09-16 2004-04-30 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
US20070248540A1 (en) * 2002-09-16 2007-10-25 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
EP1558293A4 (fr) 2002-11-04 2006-10-25 Univ California Essai de tolerance au glucose deutere ou aux graisses pour la mesure a haute capacite du metabolisme des sucres ou des acides gras dans le corps
US8460243B2 (en) 2003-06-10 2013-06-11 Abbott Diabetes Care Inc. Glucose measuring module and insulin pump combination
US7262020B2 (en) 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US7722536B2 (en) 2003-07-15 2010-05-25 Abbott Diabetes Care Inc. Glucose measuring device integrated into a holster for a personal area network device
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
WO2005094327A2 (fr) * 2004-03-29 2005-10-13 The Regents Of The University Of California Isolation de cellules epitheliales ou de leurs contenus biochimiques a partir de feces apres marquage isotopique in vivo
CA3090413C (fr) 2004-06-04 2023-10-10 Abbott Diabetes Care Inc. Surveillance du glucose et representations graphiques dans un systeme gestion de donnees
US20060120961A1 (en) * 2004-10-29 2006-06-08 Target Discovery, Inc. Glycan analysis using deuterated glucose
US7727718B2 (en) * 2005-01-04 2010-06-01 Molecular Research Center, Inc. Reagents for storage and preparation of samples for DNA analysis
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
DE502006006990D1 (de) * 2005-07-21 2010-07-01 Biovendor Lab Medicine Inc VERFAHREN ZUR BESTIMMUNG DER KONZENTRATION DER ADIPOZYTAREN FORM DES FATTY ACID BINDUNG PROTEIN (A-FABP, FABP4, aP2)
NZ594178A (en) 2006-02-27 2013-02-22 Targeted Molecular Diagnostics Llc An ex vivo method of predicting toxicity to tyrosine kinase inhibitors
US8986656B2 (en) * 2008-08-08 2015-03-24 Hirosaki University Method for evaluating specific incorporation of D-glucose into cells
EP2161580A1 (fr) * 2008-09-02 2010-03-10 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Biomarqueurs pour identifier des sujets prédisposé à développer une résistance à l'insuline et pour déterminer l'état de résistance à l'insuline
US10646594B2 (en) * 2009-06-19 2020-05-12 Case Western Reserve University Deuterated metabolic water precursor for detecting and treating diseased tissue
US9110008B2 (en) 2010-07-26 2015-08-18 Los Gatos Research Method for isotopic analysis of water in bodily fluids
US10814018B2 (en) 2010-10-25 2020-10-27 Hadasit Medical Research Service & Development Ltd. Isotopically labeled deoxy-glucose and derivatives thereof, compositions comprising them and uses thereof
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
JP2014526685A (ja) 2011-09-08 2014-10-06 ザ・リージェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア 代謝流量測定、画像化、および顕微鏡法
CA2858368A1 (fr) 2011-12-07 2013-06-13 Glaxosmithkline Llc Procedes de determination de la masse musculaire squelettique totale du corps
KR102105354B1 (ko) 2012-08-20 2020-04-29 오츠카 세이야쿠 가부시키가이샤 당대사능의 측정 방법 및 그에 사용하는 조성물
US9410963B2 (en) * 2012-12-04 2016-08-09 Nestec S.A. Hexanoylglycine as biomarker for the predisposition for weight gain and obesity
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
ES2754246T3 (es) * 2013-03-15 2020-04-16 Otsuka Pharma Co Ltd Composición para su uso en un método para medir la razón de combustión azúcar/ácido graso
JP6146872B2 (ja) * 2014-06-16 2017-06-14 日本電信電話株式会社 アセトン中の天然の安定炭素同位体比の分析方法、並びに脂質代謝のモニタリング方法
WO2016046636A2 (fr) 2014-09-05 2016-03-31 American University Of Beirut Détermination du risque de développement d'une maladie cardiovasculaire par mesure des teneurs urinaires en arn messager de podocine et de néphrine
CN105606750A (zh) * 2016-01-06 2016-05-25 大连海事大学 基于脂肪酸碳稳定同位素的水产品产地溯源方法
LU93103B1 (en) * 2016-06-10 2018-01-23 Univ Luxembourg Quality of samples
US11754478B2 (en) 2018-08-16 2023-09-12 Abb Schweiz Ag Rapid equilibrator for water isotope analysis
WO2020072279A2 (fr) * 2018-09-27 2020-04-09 Collins T Que Mesure de déplétion du deutérium
CN109239238A (zh) * 2018-11-22 2019-01-18 辽宁润生康泰生物医药科技有限公司 一种同时检测23种脂肪酸的试剂盒及其检测方法
WO2022019336A1 (fr) * 2020-07-21 2022-01-27 国立大学法人 東京大学 Composé de marquage deutéré et son procédé de production

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020041848A1 (en) * 1999-01-13 2002-04-11 Joseph Chaiken Chemically Specific Imaging Of Tissue

Family Cites Families (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3375A (en) * 1843-12-15 photo-litho
US406552A (en) * 1889-07-09 Apparatus for upsetting eye-bars
US4065552A (en) * 1975-05-05 1977-12-27 Giovanni Giacomo Costa Method of detecting malignant neoplasms
US4332784A (en) * 1979-02-06 1982-06-01 The Radiochemical Centre Limited Dual isotope assays
SU968036A1 (ru) 1980-03-10 1982-10-23 Научно-исследовательский институт медицинской радиологии АМН СССР Способ получени меченого белка
US5317098A (en) * 1986-03-17 1994-05-31 Hiroaki Shizuya Non-radioisotope tagging of fragments
DE3667103D1 (en) * 1986-06-09 1989-12-28 Bruker Analytische Messtechnik Method for determining the turnover of organic material in living tissue and nmr spectrometer for performing this method
US4940658A (en) * 1986-11-20 1990-07-10 University Patents, Inc. Assay for sulfhydryl amino acids and methods for detecting and distinguishing cobalamin and folic acid deficency
EP0335918A1 (fr) * 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Composition diagnostique ou radiotherapeutique comprenant un compose a base d'hydrogene
US5042488A (en) * 1987-09-29 1991-08-27 The Washington University Methods employing deuterium for obtaining direct, observable deuterium magnetic resonance images in vivo and in situ
US6004781A (en) * 1988-01-22 1999-12-21 The General Hospital Corporation Nucleic acid encoding Ig-CD4 fusion proteins
EP0467885A4 (en) 1989-03-20 1993-03-31 Anticancer Inc. Native-state method and system for determining viability and proliferative capacity of tissues -i(in vitro)
GB2229718B (en) * 1989-03-22 1993-01-06 Inst Molekularnoi Genetik Method for preparing hydrogen-isotape labelled biologically active organic compounds
US5217903A (en) * 1990-05-15 1993-06-08 Trustees Of Boston University Measuring connective tissue breakdown products in body fluids
US5209919A (en) * 1990-07-13 1993-05-11 Regents Of The University Of California Method of measurement in biological systems
CA2027714C (fr) * 1990-07-13 2003-01-28 Kenneth W. Turtletaub Methode de mesure pour les systemes biologiques
US5597548A (en) * 1990-07-18 1997-01-28 Board Of Regents, The University Of Texas System 13 C Isotopomer analyses in intact tissue using (13 C) homonuclear decoupling
HU208084B (en) 1991-10-31 1993-08-30 Hyd Kutato Fejlesztoe Kft Process for producing compositions suitable for curing tumorous diseases
US5394236A (en) * 1992-02-03 1995-02-28 Rutgers, The State University Methods and apparatus for isotopic analysis
AU3892593A (en) 1992-04-08 1993-11-18 Paavo Kai Johannes Kinnunen Composition for therapeutic or diagnostic use, process for its preparation and its use
US5338686A (en) * 1992-04-29 1994-08-16 Hellerstein Marc K Method for measuring in vivo synthesis of biopolymers
JP2960832B2 (ja) * 1992-05-08 1999-10-12 ペルマテック テクノロジー アクチェンゲゼルシャフト エストラジオールの投与システム
US5366885A (en) 1992-06-09 1994-11-22 Barranco Iii Sam C Method and kit for testing tumors for drug sensitivity
US5506147A (en) * 1993-04-15 1996-04-09 Kolhouse; J. Fred Non-invasive evaluation of maldigestion and malaborption
ATE162216T1 (de) * 1993-05-17 1998-01-15 Amersham Int Plc Vorrichtung und verfahren zum nachweis zellularer und biochemischer prozesse
US5439803A (en) * 1993-08-13 1995-08-08 The Regents Of The University Of Michigan Isotope and assay for glycolysis and the pentose phosphate pathway
NZ275054A (en) 1993-11-08 1997-04-24 Peptide Delivery Systems Pty L Diagnosing atherosclerosis or coronary artery disease using labelled composition which mimics essential features of an exogenous lipoprotein
ATE245035T1 (de) * 1995-08-08 2003-08-15 Otsuka Pharma Co Ltd Diagnostische zusammensetzungen und deren anwendung in der diagnose von zentralnervösen anomalien
US5922554A (en) * 1995-10-30 1999-07-13 The Regents Of The University Of California Inhibition of cellular uptake of cholesterol
EP0826377B1 (fr) 1996-08-27 2002-11-06 Tokyo Gas Co., Ltd. Agent diagnostique pour diabète
AU745236B2 (en) * 1997-02-14 2002-03-14 George Washington University, The An assay for the measurement of DNA synthesis rates
EP1008167A4 (fr) * 1997-03-14 2006-08-23 Univ George Washington Dispositif de controle continu du rapport isotopique apres des reactions chimiques au fluor
US5910403A (en) * 1997-05-15 1999-06-08 The Regents Of University Of California Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
US5961470A (en) * 1997-07-09 1999-10-05 Wagner; David A. Breath test for assessing hepatic function
US6329208B1 (en) * 1997-07-16 2001-12-11 Board Of Regents, The University Of Texas System Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling
CA2249173C (fr) * 1997-10-06 2008-12-16 Tokyo Gas Co., Ltd. Agent diagnostique pour l'exploration fonctionnelle du foie
US5924995A (en) * 1997-11-10 1999-07-20 Meretek Diagnostics Non-invasive method for the functional assessment of infants and children with an inherited metabolic disorder
US6461870B2 (en) * 1998-05-06 2002-10-08 Isotechnika Inc. 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
AU3725199A (en) * 1998-05-06 1999-11-23 Isotechnika Inc. 13c glucose breath test for the diagnosis of diabetic indications andmonitoring glycemic control
US6284219B1 (en) * 1998-06-30 2001-09-04 Phenome Sciences Inc. In vivo determination of metabolic function for use in therapy management
US6625547B1 (en) * 1998-08-05 2003-09-23 Washington State University Research Foundation Relative rates of cytochrome p450 metabolism
DE19839491A1 (de) * 1998-08-29 2000-03-02 Hermann Heumann Verfahren zur Markierung von Biopolymeren mit Isotopen
US6653076B1 (en) 1998-08-31 2003-11-25 The Regents Of The University Of Washington Stable isotope metabolic labeling for analysis of biopolymers
US6693186B2 (en) 1998-09-01 2004-02-17 Antex Biologics Inc Neisseria meningitidis polypeptide, nucleic acid sequence and uses thereof
US6887712B1 (en) * 1998-11-09 2005-05-03 Atherogenics, Inc. Methods and compositions to lower plasma cholesterol levels
WO2000063683A1 (fr) 1999-04-20 2000-10-26 Target Discovery, Inc. Procedes de cartographie peptidique de polypeptides, etablissement de profils et systeme de base de donnees bioinformatique
US6764817B1 (en) * 1999-04-20 2004-07-20 Target Discovery, Inc. Methods for conducting metabolic analyses
US20030119069A1 (en) * 1999-04-20 2003-06-26 Target Discovery, Inc. Labeling of protein samples
US6391649B1 (en) * 1999-05-04 2002-05-21 The Rockefeller University Method for the comparative quantitative analysis of proteins and other biological material by isotopic labeling and mass spectroscopy
US7057168B2 (en) * 1999-07-21 2006-06-06 Sionex Corporation Systems for differential ion mobility analysis
US6653090B1 (en) * 1999-11-05 2003-11-25 University Of Alberta Methods for measuring the metabolism of and screening for drugs in isolated hearts
JP2001211782A (ja) 2000-02-02 2001-08-07 Masa Yamamoto tob遺伝子欠損ノックアウト非ヒト哺乳動物
CA2405722A1 (fr) 2000-04-13 2001-11-08 Thermo Finnigan Llc Analyse proteomique par spectrometrie de masse parallele
JP2003532900A (ja) * 2000-05-05 2003-11-05 パーデュー・リサーチ・ファウンデーション タンパク質を同定及び定量化するための親和性により選択されるサインペプチド
JP2003533680A (ja) * 2000-05-18 2003-11-11 メタボリック ソリューションズ,インコーポレイティド リバースアイソトープ希釈アッセイ及びラクトース不耐性アッセイ
US6680203B2 (en) * 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
US7048907B2 (en) * 2001-02-05 2006-05-23 Biophysics Assay Laboratory, Inc. Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products
GB0106923D0 (en) * 2001-03-20 2001-05-09 Univ Dundee Liver function test
US7256047B2 (en) * 2001-05-01 2007-08-14 Board Of Regents, The University Of Texas System Measurement of gluconeogenesis and intermediary metabolism using stable isotopes
EP1421198A4 (fr) * 2001-06-26 2006-08-30 New York State Office Of Menta Procedures cellulaires de recherche systematique a haut rendement
US6835927B2 (en) * 2001-10-15 2004-12-28 Surromed, Inc. Mass spectrometric quantification of chemical mixture components
US7001587B2 (en) * 2001-10-24 2006-02-21 The Regents Of The University Of California Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water
US20050092910A1 (en) * 2001-12-08 2005-05-05 Scott Geromanos Method of mass spectrometry
US7635841B2 (en) * 2001-12-12 2009-12-22 Micromass Uk Limited Method of mass spectrometry
DE60324393D1 (de) 2002-02-12 2008-12-11 Univ California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
US20030180710A1 (en) * 2002-03-22 2003-09-25 Lee Wai-Nang Paul Method of enhancing the efficiency of a pharmaceutical business
US20030180800A1 (en) * 2002-03-22 2003-09-25 Lee Wai-Nang Paul Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development
US20060100903A1 (en) * 2002-03-22 2006-05-11 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Method of enhancing the efficiency of a pharmaceutical business
US20050281745A1 (en) * 2002-03-22 2005-12-22 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Stable isotope based dynamic metabolic profiling of living organisms for characterization of metabolic diseases, drug testing and drug development
JP3839335B2 (ja) * 2002-03-25 2006-11-01 富士通株式会社 学習支援方法,及び学習支援プログラム
US20030224420A1 (en) * 2002-04-05 2003-12-04 Hellerstein Marc K. Method for isolating and measuring proliferation of long-term label retaining cells and stem cells
US20030211036A1 (en) * 2002-05-07 2003-11-13 Hadassa Degani Method and apparatus for monitoring and quantitatively evaluating tumor perfusion
US7510880B2 (en) * 2002-06-26 2009-03-31 Gross Richard W Multidimensional mass spectrometry of serum and cellular lipids directly from biologic extracts
WO2004011426A2 (fr) * 2002-07-30 2004-02-05 The Regents Of The University Of California Procede de mesure automatique a grande echelle des taux de flux moleculaire proteomique ou organeomique par spectrometrie de masse
WO2004016156A2 (fr) * 2002-08-16 2004-02-26 The Regents Of The University Of California Test de tolerance au glucose a recyclage hepatique dynamique
WO2004021863A2 (fr) * 2002-09-04 2004-03-18 The Regents Of The University Of California Procedes de mesure des vitesses de replication et du taux de mortalite d'agents microbiens infectieux dans un organisme hote infecte
ATE415486T1 (de) 2002-09-13 2008-12-15 Univ California Verfahren zur messung der geschwindigkeiten des cholesterinrückwärtstransports in vivo als index für anti-artherogenese
AU2003275037A1 (en) * 2002-09-16 2004-04-30 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
US20070248540A1 (en) 2002-09-16 2007-10-25 The Regents Of The University Of California Biochemical methods for measuring metabolic fitness of tissues or whole organisms
CA2800040C (fr) * 2002-10-29 2015-12-29 Target Discovery, Inc. Procede permettant d'accroitre l'efficacite d'ionisation en spectroscopie de masse
EP1558293A4 (fr) 2002-11-04 2006-10-25 Univ California Essai de tolerance au glucose deutere ou aux graisses pour la mesure a haute capacite du metabolisme des sucres ou des acides gras dans le corps
US20040121305A1 (en) * 2002-12-18 2004-06-24 Wiegand Roger Charles Generation of efficacy, toxicity and disease signatures and methods of use thereof
JP2006522340A (ja) * 2003-04-02 2006-09-28 メルク エンド カムパニー インコーポレーテッド 質量分析データの分析法
US20050014181A1 (en) * 2003-06-18 2005-01-20 Galis Zorina S. Methods and compositions for the assessment of polymer assembly
WO2005001736A2 (fr) * 2003-06-30 2005-01-06 Ajinomoto Co., Inc. Methode d'analyse de flux metabolique intracellulaire au moyen d'un substrat marque par un isotope
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
JP4206031B2 (ja) * 2003-11-10 2009-01-07 Sriスポーツ株式会社 アイアン型ゴルフクラブヘッド
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
US8510054B2 (en) * 2004-02-05 2013-08-13 Ajinomoto Co., Inc. Intracellular metabolic flux analysis method using substrate labeled with isotope
TW200538738A (en) * 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
AU2005222430A1 (en) * 2004-03-11 2005-09-22 The Regents Of University Of California Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
WO2005094327A2 (fr) * 2004-03-29 2005-10-13 The Regents Of The University Of California Isolation de cellules epitheliales ou de leurs contenus biochimiques a partir de feces apres marquage isotopique in vivo
WO2005098024A1 (fr) 2004-03-30 2005-10-20 Kinemed, Inc. Mesure in vivo des flux relatifs a travers la ribonucleotide reductase par rapport aux voies du desoxyribonucleoside au moyen d'isotopes
JP4654592B2 (ja) * 2004-04-02 2011-03-23 味の素株式会社 代謝フラックスの決定方法
US20060120961A1 (en) * 2004-10-29 2006-06-08 Target Discovery, Inc. Glycan analysis using deuterated glucose
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020041848A1 (en) * 1999-01-13 2002-04-11 Joseph Chaiken Chemically Specific Imaging Of Tissue

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DEUTERIUM AS AN INDICATOR IN THE STUDY OF INTERMEDIARY METABOLISM *
ENDOGENOUS GLUCOSE PRODUCTION AND GLUCOSE EFFECTIVENESS IN TYPE 2 DIABETIC SUBJECTS DERIVED FROM STABLE-LABELED MIM *

Also Published As

Publication number Publication date
US20100041082A1 (en) 2010-02-18
WO2004042360A3 (fr) 2004-09-10
AU2003291731A1 (en) 2004-06-07
US20040115131A1 (en) 2004-06-17
US7910323B2 (en) 2011-03-22
US7504233B2 (en) 2009-03-17
AU2003291731B2 (en) 2009-09-10
CA2504313C (fr) 2012-01-17
JP4611025B2 (ja) 2011-01-12
WO2004042360A2 (fr) 2004-05-21
EP1558293A4 (fr) 2006-10-25
JP2006505777A (ja) 2006-02-16
CA2504313A1 (fr) 2004-05-21
EP1558293A2 (fr) 2005-08-03

Similar Documents

Publication Publication Date Title
SG152922A1 (en) Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
Gravholt et al. Turner syndrome: mechanisms and management
Davis et al. Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study
Kong et al. Physical changes in white and brown rice during simulated gastric digestion
Bruun et al. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects
de Carvalho et al. Plasma glucose and insulin responses after consumption of breakfasts with different sources of soluble fiber in type 2 diabetes patients: a randomized crossover clinical trial
Gram et al. Skeletal muscle mitochondrial H2O2 emission increases with immobilization and decreases after aerobic training in young and older men
Howard et al. Oxidative protein damage is associated with poor grip strength among older women living in the community
Matias et al. Endocannabinoids measurement in human saliva as potential biomarker of obesity
Kim et al. Integrative physiology: defined novel metabolic roles of osteocalcin
Goynumer et al. Vascular risk in women with a history of severe preeclampsia
Lund et al. Low-grade inflammation independently associates with cardiometabolic risk in children with overweight/obesity
Chen et al. Total cardiovascular risk profile of Taiwanese vegetarians
Jahren et al. The potential for a carbon stable isotope biomarker of dietary sugar intake
Pinto et al. Early and sustained exposure to high-sucrose diet triggers hippocampal ER stress in young rats
Illien‐Jünger et al. Dietary advanced glycation end products have sex‐and age‐dependent effects on vertebral bone microstructure and mechanical function in mice
Skilton et al. The association of dietary alpha-linolenic acid with blood pressure and subclinical atherosclerosis in people born small for gestational age: the Special Turku Coronary Risk Factor Intervention Project study
Horner et al. Biomarkers of appetite: is there a potential role for metabolomics?
Toledo-Corral et al. Persistence of the metabolic syndrome and its influence on carotid artery intima media thickness in overweight Latino children
Takahashi et al. Effects of breaking sitting by standing and acute exercise on postprandial oxidative stress
Sarhat et al. Characteristic abnormalities in serum biochemistry during congestive heart failure
Tan et al. Dietary copper and selenium are associated with insulin resistance in overweight and obese Malaysian adults
Krebs et al. Cardiovascular risk in pediatric type 1 diabetes: sex‐specific intima‐media thickening verified by automatic contour identification and analyzing systems
Syrenicz et al. Relation of low-grade inflammation and endothelial activation to blood pressure in obese children and adolescents
Klimek et al. Effect of fetal and infant malnutrition on metabolism in older age